RxDoctor Payments Data

Jaclyn Schumann

Podiatrist · Joliet, ILNPI 1184121030

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (34.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Arthrex at 56.9% of the total. Reporting peaked in 2021 at $13,566 and has fallen 51.0% since, to $6,643 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,792in general payments, 2019–2025

Across 141 payments — averaging $204.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$16K
  • Stryker$6K
  • Medwest Associates$2K
  • Kerecis Limited$1K
  • Paragon 28, Inc.$961
  • Lightbody Medical Technologies Inc$830
  • plus $2K from 16 others

What the payments were for

  • Speaking & faculty fees$2,5009%
  • Grants$10,00035%
  • Travel & lodging$5,76220%
  • Food & beverage$6,36122%
  • Education$4,16914%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,792 in reported general payments places this provider in the 95th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$393,473
Medicare patients
255
Services billed
2,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole41$993
Ciclopirox23$395
Gabapentin41$242
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$187
Naproxen19$162
Cephalexin13$112
Methylprednisolone23$100
Meloxicam44$70

Paid to pharmacies, not to this prescriber.

Other podiatrist in Joliet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →